Research Project · Health
METAvivor Translational Research Award
METAvivormetavivor.org (opens in a new tab)Catalog updated
- Amount
- $450,000
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- established investigators
About this program
METAvivor Research Foundation is funding mechanistic, diagnostic, and therapeutic research into metastatic breast cancer, including studies addressing treatment side effects and quality-of-life improvements. Awards for 2026 include a Translational Research Award (up to $450,000 total over three years) for established investigators, an Early Career Investigator Award (up to $200,000 total over two years) for investigators within 10 years of their terminal degree and within six years of starting their first non‑tenured faculty position, and a Research Advisor’s Award for members of METAvivor’s Scientific Advisory Board. Applicants must hold a clinical doctoral degree or a doctoral degree and be actively engaged in metastatic breast cancer research or treatment; early career applicants must submit a Letter of Intent (approximately 30% of LOIs will be invited to submit full applications).
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules and the announcement in full.
Ask for a demo of this program The form opens already filled in.